Triethylene glycol monoethyl ether
Common Name: |
Triethylene glycol monoethyl ether |
IUPAC Name: |
2-[2-(2-ethoxyethoxy)ethoxy]ethanol |
Molecular Formula: |
C8H18O4 |
SMILES: |
CCOCCOCCOCCO |
Inchi: |
1S/C8H18O4/c1-2-10-5-6-12-8-7-11-4-3-9/h9H,2-8H2,1H3 |
Inchi Key: |
WFSMVVDJSNMRAR-UHFFFAOYSA-N |
Cas No: |
112-50-5 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
1 |
Name |
Value |
Molecular Weight (g/mol) |
178.23 |
Mass (g/mol) |
178.121 |
Molar Refractivity |
44.99 |
Net Charge |
|
HBD |
1 |
HBA |
4 |
Rt Bonds |
9 |
Rings |
|
TPSA |
47.92 |
Hetero Atoms |
4 |
Heavy Atoms |
12 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
-18.7 |
Boiling Point (°C@760.00mm Hg) |
256 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
1.00 |
LogP |
0.048 |
iLOGP |
2.41 |
XLOGP3 |
-0.69 |
WLOGP |
0.05 |
MLOGP |
-0.44 |
ESOL Log S |
0.08 |
ESOL Solubility (mg/ml) |
216 |
ESOL Solubility (mol/l) |
1.21 |
ESOL Class: esol_class |
Highly soluble |
Ali Log S |
0.16 |
Ali Solubility (mg/ml) |
257 |
Ali Solubility (mol/l) |
1.44 |
Ali Class |
Highly soluble |
Silicos-IT LogSw |
-1.75 |
Silicos-IT Solubility (mg/ml) |
3.21 |
Silicos-IT Solubility (mol/l) |
0.02 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
0 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-7.88 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.536 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
1.847 |
Carcinogenicity (Binary) |
1 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |